ABT-737,BH3模拟Bcl-xL,Bcl-2和Bcl-w抑制剂

ABT-737 (订货以英文为准)

编号:A127419
CAS号:852808-04-9
分子式:C42H45CLN6O5S2
分子量:813.43
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A127419-25mg 阿拉丁 25mg ¥1464.90
A127419-100mg 阿拉丁 100mg ¥5076.90
A127419-5mg 阿拉丁 5mg ¥502.90
产品名称 ABT-737
中文名称 ABT-737,BH3模拟Bcl-xL,Bcl-2和Bcl-w抑制剂
CAS号 852808-04-9
分子式(M.F.) C42H45CLN6O5S2
分子量(M.W.) 813.43
储存条件 -20°C储存
熔点148-151° C
折光率1.70
溶解性DMSO ≥160mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL
存贮条件储存温度-20°C
密度1.4000
应用A selective inhibitor of Bcl-2
产品介绍ABT-737是 Bcl-xL, Bcl-2 和 Bcl-w抑制剂,EC50分别为78.7 nM,30.3 nM和197.8 nM。对Mcl-1, Bcl-B 和 Bfl-1无抑制性。
备注ABT-737 is a BH3 mimetic inhibitor of Bcl-xL, Bcl-2 and Bcl-w with EC50 of 78.7 nM, 30.3 nM and 197.8 nM, respectively; no inhibition observed against Mcl-1, Bcl-B or Bfl-1. Phase 2.
生化机理ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and xenografts. Increased expression of the Bcl-2 family of proteins in cancers has been associated with chemotherapy resistance, inhibiting Bcl-2 or Bcl-XL overexpression could potentially induce apoptosis in cancer cells while having minimal effects on normal cells.
别名ABT737;ABT 737; 4-(4-((4'-氯(1,1'-联苯)-2-基)甲基)-1-哌嗪基)-N-((4-(((1R)-3-(二甲基氨基)-1-((苯硫基)甲基)丙基)氨基)-3-硝基苯基)磺酰基)苯甲酰胺;;ABT737;ABT 737;4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4- (dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl] sulfonylbenzamide
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:2098-66-0
¥ 3545.00 C829982-100mg
¥ 200.00 100566-100g
CAS号:87-66-1
¥ 26.00 P-98650+25g-25g
CAS号:53784-84-2
¥ 748.80 X170299A-100mg
CAS号:747-36-4
¥ 100.00 B28598-20mg
CAS号:29667-48-9
¥ 2136.90 M633548-100mg
CAS号:1380005-74-2
¥ 1468.80 X192029A-100mg
CAS号:61349-72-2
¥ 1995.00 1958347-100mg